Arrowhead Pharmaceuticals, Inc. (ARWR)
73.60
-0.31
(-0.42%)
USD |
NASDAQ |
Apr 27, 16:00
73.54
-0.06
(-0.08%)
After-Hours: 06:32
Arrowhead Pharmaceuticals Market Cap : 10.31B for April 27, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Sarepta Therapeutics, Inc. | 2.203B |
| Johnson & Johnson | 542.44B |
| Merck & Co., Inc. | 272.53B |
| ACADIA Pharmaceuticals, Inc. | 3.802B |
| Alnylam Pharmaceuticals, Inc. | 40.92B |
Market Cap Related Metrics
| PE Ratio | 47.85 |
| PS Ratio | 9.275 |
| Price to Book Value | 18.13 |
| Price to Free Cash Flow | 30.94 |
| Price | 73.60 |
| Earnings Yield | 2.09% |
| Operating PE Ratio | 33.67 |
| Normalized PE Ratio | 47.85 |